The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of survival after metastasectomy of oligometastatic recurrence following gastroesophageal cancer treatment.
 
Malcolm MacKenzie
No Relationships to Disclose
 
Lucy Xiaolu Ma
No Relationships to Disclose
 
Osvaldo Epsin-Garcia
No Relationships to Disclose
 
Chihiro Suzuki
No Relationships to Disclose
 
Yvonne Bach
No Relationships to Disclose
 
Michael J Allen
No Relationships to Disclose
 
Gail Elizabeth Darling
No Relationships to Disclose
 
Carol Jane Swallow
No Relationships to Disclose
 
Savtaj Singh Brar
No Relationships to Disclose
 
Jonathan Yeung
No Relationships to Disclose
 
Sangeetha Kalimuthu
No Relationships to Disclose
 
Rebecca Wong
No Relationships to Disclose
 
Elan David Panov
No Relationships to Disclose
 
Patrick Veit-Haibach
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - Bayer; Eisai; Roche Canada
Research Funding - AstraZeneca/MedImmune; Boston Biomedical; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Mirati Therapeutics; Novartis
 
Elena Elimova
Employment - Merck (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Zymeworks (Inst)
Research Funding - Bristol-Myers Squibb; Zymeworks
 
Raymond Woo-Jun Jang
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis (Inst); Eisai; Ipsen; Ipsen; Novartis
Research Funding - AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)